Special Issue "Metabolic Syndrome from the Perspectives of Genetics, Genomics and Proteomics"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 1361
Interests: genetics; genomics; diabetes; metabolic syndrome
Interests: cerebral ischemic stroke; neuroinflammation; neuroprotective drug discovery; diabetes and its complications especially microvascular; gene expression and epigenetic regulation
Special Issues, Collections and Topics in MDPI journals
Metabolic syndrome (MetS) is the cluster of various metabolic abnormalities that includes high blood glucose levels, hypertension, hyperlipidemia, abdominal obesity as well as low HDL levels sometimes. The World Health Organization illustrates that the presence of three or more of these metabolic abnormalities constitutes metabolic syndrome. According to data from the IDF Atlas, global prevalence of diabetes—which is the highest contributor towards MetS—is at 8.8% and is only increasing; MetS, which is more than three times more common than diabetes itself, can be estimated to effect 25% of the world population.
Recent advancements in genetics and genomics approaches have allowed us to better understand metabolic diseases. For example, recent genome-wide association studies (GWAS) have identified many new loci and genes associated with BMI and blood glucose levels. Moreover, advanced genomics and other multi-omics approaches have enabled us to study these new loci and genes more robustly in a high-throughput manner.
This Special Issue invites articles which study various aspects of metabolic syndrome in regard to advanced genetics, genomics and proteomics approaches and that shed new light on various aspects of metabolic diseases.
Dr. Gautam Kumar Pandey
Dr. Prabu Paramasivam
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- metabolic syndrome
- type 2 diabetes